Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$418,673
-$1,843,577 QoQ
Shares Held
101,867
-70.1% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Campbell & CO Investment Adviser LLC holds $18,794,275 across 13 Drug Manufacturers - Specialty & Generic names. EOLS ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
328,890 | $4,443,303 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,434 | $3,815,233 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
96,079 | $2,928,487 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
73,233 | $2,421,815 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
27,606 | $1,526,887 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
54,422 | $756,465 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
60,620 | $753,506 | |
| 8 | HLN |
Haleon plc
|
64,274 | $643,382 |
All Filings in EOLS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $418,673 | 101,867 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,262,250 | 340,188 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $119,932 | 19,533 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $434,315 | 47,157 | Shares | Sole | 2025-08-07 | |
| 2024-06-30 | $229,130 | 21,118 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $1,376,544 | 130,726 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $262,500 | 28,720 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||